Global Recombinant Human Annexin A1 Protein Market Research Report 2026(Status and Outlook)
The global Recombinant Human Annexin A1 Protein market size was estimated at USD 35.42 million in 2025 and is projected to grow at a compound annual growth rate (CAGR) of 8.75% during the forecast period.
This report offers a comprehensive and in-depth analysis of the global Recombinant Human Annexin A1 Protein market, covering all critical facets from a broad macroeconomic overview to detailed micro-level insights. It examines market size, competitive landscape, emerging development trends, niche segments, key drivers and challenges, as well as conducts SWOT and value chain analyses.
The insights provided enable readers to understand the competitive dynamics within the industry and formulate effective strategies to enhance profitability and market positioning. Additionally, the report presents a clear framework for evaluating the current status and future outlook of business organizations operating in this sector.
A significant focus of this report lies in the competitive landscape of the global Recombinant Human Annexin A1 Protein market. It offers detailed profiles of major players, including their market shares, performance metrics, product portfolios, and operational status. This enables stakeholders to identify leading competitors and gain a nuanced understanding of market rivalry and structure.
In summary, this report serves as an essential resource for industry participants, investors, researchers, consultants, and business strategists, as well as anyone planning to enter or expand their presence in the Recombinant Human Annexin A1 Protein market.
Global Recombinant Human Annexin A1 Protein Market: Market Segmentation Analysis
This research report provides a detailed segmentation of the market by region (country), key manufacturers, product type, and application. Market segmentation divides the overall market into distinct subsets based on factors such as product categories, end-user industries, geographic locations, and other relevant criteria.
A clear understanding of these market segments enables decision-makers to tailor their product development, sales, and marketing strategies more effectively to meet the unique needs of each segment. Leveraging market segmentation insights can significantly enhance targeted approaches, optimize resource allocation, and accelerate product innovation cycles by aligning offerings with the specific demands of diverse customer groups.
Key Company
Abcam
Novus Biologicals
QED Bioscience
Elabscience
Assay Genie
Labome
Active Bioscience
Boster Bio
Lifespan Biosciences
RayBiotech
Protein Alternatives
enQuire BioReagents
Abeomics
Creative BioMart
KMD Bioscience
OriGene
MedChemExpress
Cusabio
Canvax
Biorbyt
Bon Opus Biosciences
Prospec Bio
Neuromics
Market Segmentation (by Type)
>85%
>90%
>95%
Others
Market Segmentation (by Application)
ELISA
WB
Antibody Production
Protein Array
Others
Geographic Segmentation
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Recombinant Human Annexin A1 Protein Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Recombinant Human Annexin A1 Protein, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
Key Reasons to Buy this Report:
Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
This enables you to anticipate market changes to remain ahead of your competitors
You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
Provision of market value data for each segment and sub-segment
Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Includes in-depth analysis of the market from various perspectives through Porter?s five forces analysis
Provides insight into the market through Value Chain
Market dynamics scenario, along with growth opportunities of the market in the years to come
6-month post-sales analyst support
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
This report offers a comprehensive and in-depth analysis of the global Recombinant Human Annexin A1 Protein market, covering all critical facets from a broad macroeconomic overview to detailed micro-level insights. It examines market size, competitive landscape, emerging development trends, niche segments, key drivers and challenges, as well as conducts SWOT and value chain analyses.
The insights provided enable readers to understand the competitive dynamics within the industry and formulate effective strategies to enhance profitability and market positioning. Additionally, the report presents a clear framework for evaluating the current status and future outlook of business organizations operating in this sector.
A significant focus of this report lies in the competitive landscape of the global Recombinant Human Annexin A1 Protein market. It offers detailed profiles of major players, including their market shares, performance metrics, product portfolios, and operational status. This enables stakeholders to identify leading competitors and gain a nuanced understanding of market rivalry and structure.
In summary, this report serves as an essential resource for industry participants, investors, researchers, consultants, and business strategists, as well as anyone planning to enter or expand their presence in the Recombinant Human Annexin A1 Protein market.
Global Recombinant Human Annexin A1 Protein Market: Market Segmentation Analysis
This research report provides a detailed segmentation of the market by region (country), key manufacturers, product type, and application. Market segmentation divides the overall market into distinct subsets based on factors such as product categories, end-user industries, geographic locations, and other relevant criteria.
A clear understanding of these market segments enables decision-makers to tailor their product development, sales, and marketing strategies more effectively to meet the unique needs of each segment. Leveraging market segmentation insights can significantly enhance targeted approaches, optimize resource allocation, and accelerate product innovation cycles by aligning offerings with the specific demands of diverse customer groups.
Key Company
Abcam
Novus Biologicals
QED Bioscience
Elabscience
Assay Genie
Labome
Active Bioscience
Boster Bio
Lifespan Biosciences
RayBiotech
Protein Alternatives
enQuire BioReagents
Abeomics
Creative BioMart
KMD Bioscience
OriGene
MedChemExpress
Cusabio
Canvax
Biorbyt
Bon Opus Biosciences
Prospec Bio
Neuromics
Market Segmentation (by Type)
>85%
>90%
>95%
Others
Market Segmentation (by Application)
ELISA
WB
Antibody Production
Protein Array
Others
Geographic Segmentation
- North America (USA, Canada, Mexico)
- Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
- South America (Brazil, Argentina, Columbia, Rest of South America)
- The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
- Industry drivers, restraints, and opportunities covered in the study
- Neutral perspective on the market performance
- Recent industry trends and developments
- Competitive landscape & strategies of key players
- Potential & niche segments and regions exhibiting promising growth covered
- Historical, current, and projected market size, in terms of value
- In-depth analysis of the Recombinant Human Annexin A1 Protein Market
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Recombinant Human Annexin A1 Protein Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Recombinant Human Annexin A1 Protein, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
Key Reasons to Buy this Report:
Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
This enables you to anticipate market changes to remain ahead of your competitors
You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
Provision of market value data for each segment and sub-segment
Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Includes in-depth analysis of the market from various perspectives through Porter?s five forces analysis
Provides insight into the market through Value Chain
Market dynamics scenario, along with growth opportunities of the market in the years to come
6-month post-sales analyst support
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE
1.1 Market Definition and Statistical Scope of Recombinant Human Annexin A1 Protein
1.2 Key Market Segments
1.2.1 Recombinant Human Annexin A1 Protein Segment by Type
1.2.2 Recombinant Human Annexin A1 Protein Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 RECOMBINANT HUMAN ANNEXIN A1 PROTEIN MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Recombinant Human Annexin A1 Protein Market Size (M USD) Estimates and Forecasts (2020-2035)
2.1.2 Global Recombinant Human Annexin A1 Protein Sales Estimates and Forecasts (2020-2035)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 RECOMBINANT HUMAN ANNEXIN A1 PROTEIN MARKET COMPETITIVE LANDSCAPE
3.1 Company Assessment Quadrant
3.2 Global Recombinant Human Annexin A1 Protein Product Life Cycle
3.3 Global Recombinant Human Annexin A1 Protein Sales by Manufacturers (2020-2025)
3.4 Global Recombinant Human Annexin A1 Protein Revenue Market Share by Manufacturers (2020-2025)
3.5 Recombinant Human Annexin A1 Protein Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Recombinant Human Annexin A1 Protein Average Price by Manufacturers (2020-2025)
3.7 Manufacturers? Manufacturing Sites, Areas Served, and Product Types
3.8 Recombinant Human Annexin A1 Protein Market Competitive Situation and Trends
3.8.1 Recombinant Human Annexin A1 Protein Market Concentration Rate
3.8.2 Global 5 and 10 Largest Recombinant Human Annexin A1 Protein Players Market Share by Revenue
3.8.3 Mergers & Acquisitions, Expansion
4 RECOMBINANT HUMAN ANNEXIN A1 PROTEIN INDUSTRY CHAIN ANALYSIS
4.1 Recombinant Human Annexin A1 Protein Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF RECOMBINANT HUMAN ANNEXIN A1 PROTEIN MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
5.4.1 New Product Developments
5.4.2 Mergers & Acquisitions
5.4.3 Expansions
5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
5.5.1 Industry Policies Analysis
5.5.2 Economic Environment Analysis
5.5.3 Social Environment Analysis
5.5.4 Technological Environment Analysis
5.6 Global Recombinant Human Annexin A1 Protein Market Porter's Five Forces Analysis
5.6.1 Global Trade Frictions
5.6.2 U.S. Tariff Policy ? April 2025
5.6.3 Global Trade Frictions and Their Impacts to Recombinant Human Annexin A1 Protein Market
5.7 ESG Ratings of Leading Companies
6 RECOMBINANT HUMAN ANNEXIN A1 PROTEIN MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Recombinant Human Annexin A1 Protein Sales Market Share by Type (2020-2025)
6.3 Global Recombinant Human Annexin A1 Protein Market Size by Type (2020-2025)
6.4 Global Recombinant Human Annexin A1 Protein Price by Type (2020-2025)
7 RECOMBINANT HUMAN ANNEXIN A1 PROTEIN MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Recombinant Human Annexin A1 Protein Market Sales by Application (2020-2025)
7.3 Global Recombinant Human Annexin A1 Protein Market Size (M USD) by Application (2020-2025)
7.4 Global Recombinant Human Annexin A1 Protein Sales Growth Rate by Application (2020-2025)
8 RECOMBINANT HUMAN ANNEXIN A1 PROTEIN MARKET SALES BY REGION
8.1 Global Recombinant Human Annexin A1 Protein Sales by Region
8.1.1 Global Recombinant Human Annexin A1 Protein Sales by Region
8.1.2 Global Recombinant Human Annexin A1 Protein Sales Market Share by Region
8.2 Global Recombinant Human Annexin A1 Protein Market Size by Region
8.2.1 Global Recombinant Human Annexin A1 Protein Market Size by Region
8.2.2 Global Recombinant Human Annexin A1 Protein Market Size by Region
8.3 North America
8.3.1 North America Recombinant Human Annexin A1 Protein Sales by Country
8.3.2 North America Recombinant Human Annexin A1 Protein Market Size by Country
8.3.3 U.S. Market Overview
8.3.4 Canada Market Overview
8.3.5 Mexico Market Overview
8.4 Europe
8.4.1 Europe Recombinant Human Annexin A1 Protein Sales by Country
8.4.2 Europe Recombinant Human Annexin A1 Protein Market Size by Country
8.4.3 Germany Market Overview
8.4.4 France Market Overview
8.4.5 U.K. Market Overview
8.4.6 Italy Market Overview
8.4.7 Spain Market Overview
8.5 Asia Pacific
8.5.1 Asia Pacific Recombinant Human Annexin A1 Protein Sales by Region
8.5.2 Asia Pacific Recombinant Human Annexin A1 Protein Market Size by Region
8.5.3 China Market Overview
8.5.4 Japan Market Overview
8.5.5 South Korea Market Overview
8.5.6 India Market Overview
8.5.7 Southeast Asia Market Overview
8.6 South America
8.6.1 South America Recombinant Human Annexin A1 Protein Sales by Country
8.6.2 South America Recombinant Human Annexin A1 Protein Market Size by Country
8.6.3 Brazil Market Overview
8.6.4 Argentina Market Overview
8.6.5 Columbia Market Overview
8.7 Middle East and Africa
8.7.1 Middle East and Africa Recombinant Human Annexin A1 Protein Sales by Region
8.7.2 Middle East and Africa Recombinant Human Annexin A1 Protein Market Size by Region
8.7.3 Saudi Arabia Market Overview
8.7.4 UAE Market Overview
8.7.5 Egypt Market Overview
8.7.6 Nigeria Market Overview
8.7.7 South Africa Market Overview
9 RECOMBINANT HUMAN ANNEXIN A1 PROTEIN MARKET PRODUCTION BY REGION
9.1 Global Production of Recombinant Human Annexin A1 Protein by Region(2020-2025)
9.2 Global Recombinant Human Annexin A1 Protein Revenue Market Share by Region (2020-2025)
9.3 Global Recombinant Human Annexin A1 Protein Production, Revenue, Price and Gross Margin (2020-2025)
9.4 North America Recombinant Human Annexin A1 Protein Production
9.4.1 North America Recombinant Human Annexin A1 Protein Production Growth Rate (2020-2025)
9.4.2 North America Recombinant Human Annexin A1 Protein Production, Revenue, Price and Gross Margin (2020-2025)
9.5 Europe Recombinant Human Annexin A1 Protein Production
9.5.1 Europe Recombinant Human Annexin A1 Protein Production Growth Rate (2020-2025)
9.5.2 Europe Recombinant Human Annexin A1 Protein Production, Revenue, Price and Gross Margin (2020-2025)
9.6 Japan Recombinant Human Annexin A1 Protein Production (2020-2025)
9.6.1 Japan Recombinant Human Annexin A1 Protein Production Growth Rate (2020-2025)
9.6.2 Japan Recombinant Human Annexin A1 Protein Production, Revenue, Price and Gross Margin (2020-2025)
9.7 China Recombinant Human Annexin A1 Protein Production (2020-2025)
9.7.1 China Recombinant Human Annexin A1 Protein Production Growth Rate (2020-2025)
9.7.2 China Recombinant Human Annexin A1 Protein Production, Revenue, Price and Gross Margin (2020-2025)
10 KEY COMPANIES PROFILE
10.1 Abcam
10.1.1 Abcam Basic Information
10.1.2 Abcam Recombinant Human Annexin A1 Protein Product Overview
10.1.3 Abcam Recombinant Human Annexin A1 Protein Product Market Performance
10.1.4 Abcam Business Overview
10.1.5 Abcam SWOT Analysis
10.1.6 Abcam Recent Developments
10.2 Novus Biologicals
10.2.1 Novus Biologicals Basic Information
10.2.2 Novus Biologicals Recombinant Human Annexin A1 Protein Product Overview
10.2.3 Novus Biologicals Recombinant Human Annexin A1 Protein Product Market Performance
10.2.4 Novus Biologicals Business Overview
10.2.5 Novus Biologicals SWOT Analysis
10.2.6 Novus Biologicals Recent Developments
10.3 QED Bioscience
10.3.1 QED Bioscience Basic Information
10.3.2 QED Bioscience Recombinant Human Annexin A1 Protein Product Overview
10.3.3 QED Bioscience Recombinant Human Annexin A1 Protein Product Market Performance
10.3.4 QED Bioscience Business Overview
10.3.5 QED Bioscience SWOT Analysis
10.3.6 QED Bioscience Recent Developments
10.4 Elabscience
10.4.1 Elabscience Basic Information
10.4.2 Elabscience Recombinant Human Annexin A1 Protein Product Overview
10.4.3 Elabscience Recombinant Human Annexin A1 Protein Product Market Performance
10.4.4 Elabscience Business Overview
10.4.5 Elabscience Recent Developments
10.5 Assay Genie
10.5.1 Assay Genie Basic Information
10.5.2 Assay Genie Recombinant Human Annexin A1 Protein Product Overview
10.5.3 Assay Genie Recombinant Human Annexin A1 Protein Product Market Performance
10.5.4 Assay Genie Business Overview
10.5.5 Assay Genie Recent Developments
10.6 Labome
10.6.1 Labome Basic Information
10.6.2 Labome Recombinant Human Annexin A1 Protein Product Overview
10.6.3 Labome Recombinant Human Annexin A1 Protein Product Market Performance
10.6.4 Labome Business Overview
10.6.5 Labome Recent Developments
10.7 Active Bioscience
10.7.1 Active Bioscience Basic Information
10.7.2 Active Bioscience Recombinant Human Annexin A1 Protein Product Overview
10.7.3 Active Bioscience Recombinant Human Annexin A1 Protein Product Market Performance
10.7.4 Active Bioscience Business Overview
10.7.5 Active Bioscience Recent Developments
10.8 Boster Bio
10.8.1 Boster Bio Basic Information
10.8.2 Boster Bio Recombinant Human Annexin A1 Protein Product Overview
10.8.3 Boster Bio Recombinant Human Annexin A1 Protein Product Market Performance
10.8.4 Boster Bio Business Overview
10.8.5 Boster Bio Recent Developments
10.9 Lifespan Biosciences
10.9.1 Lifespan Biosciences Basic Information
10.9.2 Lifespan Biosciences Recombinant Human Annexin A1 Protein Product Overview
10.9.3 Lifespan Biosciences Recombinant Human Annexin A1 Protein Product Market Performance
10.9.4 Lifespan Biosciences Business Overview
10.9.5 Lifespan Biosciences Recent Developments
10.10 RayBiotech
10.10.1 RayBiotech Basic Information
10.10.2 RayBiotech Recombinant Human Annexin A1 Protein Product Overview
10.10.3 RayBiotech Recombinant Human Annexin A1 Protein Product Market Performance
10.10.4 RayBiotech Business Overview
10.10.5 RayBiotech Recent Developments
10.11 Protein Alternatives
10.11.1 Protein Alternatives Basic Information
10.11.2 Protein Alternatives Recombinant Human Annexin A1 Protein Product Overview
10.11.3 Protein Alternatives Recombinant Human Annexin A1 Protein Product Market Performance
10.11.4 Protein Alternatives Business Overview
10.11.5 Protein Alternatives Recent Developments
10.12 enQuire BioReagents
10.12.1 enQuire BioReagents Basic Information
10.12.2 enQuire BioReagents Recombinant Human Annexin A1 Protein Product Overview
10.12.3 enQuire BioReagents Recombinant Human Annexin A1 Protein Product Market Performance
10.12.4 enQuire BioReagents Business Overview
10.12.5 enQuire BioReagents Recent Developments
10.13 Abeomics
10.13.1 Abeomics Basic Information
10.13.2 Abeomics Recombinant Human Annexin A1 Protein Product Overview
10.13.3 Abeomics Recombinant Human Annexin A1 Protein Product Market Performance
10.13.4 Abeomics Business Overview
10.13.5 Abeomics Recent Developments
10.14 Creative BioMart
10.14.1 Creative BioMart Basic Information
10.14.2 Creative BioMart Recombinant Human Annexin A1 Protein Product Overview
10.14.3 Creative BioMart Recombinant Human Annexin A1 Protein Product Market Performance
10.14.4 Creative BioMart Business Overview
10.14.5 Creative BioMart Recent Developments
10.15 KMD Bioscience
10.15.1 KMD Bioscience Basic Information
10.15.2 KMD Bioscience Recombinant Human Annexin A1 Protein Product Overview
10.15.3 KMD Bioscience Recombinant Human Annexin A1 Protein Product Market Performance
10.15.4 KMD Bioscience Business Overview
10.15.5 KMD Bioscience Recent Developments
10.16 OriGene
10.16.1 OriGene Basic Information
10.16.2 OriGene Recombinant Human Annexin A1 Protein Product Overview
10.16.3 OriGene Recombinant Human Annexin A1 Protein Product Market Performance
10.16.4 OriGene Business Overview
10.16.5 OriGene Recent Developments
10.17 MedChemExpress
10.17.1 MedChemExpress Basic Information
10.17.2 MedChemExpress Recombinant Human Annexin A1 Protein Product Overview
10.17.3 MedChemExpress Recombinant Human Annexin A1 Protein Product Market Performance
10.17.4 MedChemExpress Business Overview
10.17.5 MedChemExpress Recent Developments
10.18 Cusabio
10.18.1 Cusabio Basic Information
10.18.2 Cusabio Recombinant Human Annexin A1 Protein Product Overview
10.18.3 Cusabio Recombinant Human Annexin A1 Protein Product Market Performance
10.18.4 Cusabio Business Overview
10.18.5 Cusabio Recent Developments
10.19 Canvax
10.19.1 Canvax Basic Information
10.19.2 Canvax Recombinant Human Annexin A1 Protein Product Overview
10.19.3 Canvax Recombinant Human Annexin A1 Protein Product Market Performance
10.19.4 Canvax Business Overview
10.19.5 Canvax Recent Developments
10.20 Biorbyt
10.20.1 Biorbyt Basic Information
10.20.2 Biorbyt Recombinant Human Annexin A1 Protein Product Overview
10.20.3 Biorbyt Recombinant Human Annexin A1 Protein Product Market Performance
10.20.4 Biorbyt Business Overview
10.20.5 Biorbyt Recent Developments
10.21 Bon Opus Biosciences
10.21.1 Bon Opus Biosciences Basic Information
10.21.2 Bon Opus Biosciences Recombinant Human Annexin A1 Protein Product Overview
10.21.3 Bon Opus Biosciences Recombinant Human Annexin A1 Protein Product Market Performance
10.21.4 Bon Opus Biosciences Business Overview
10.21.5 Bon Opus Biosciences Recent Developments
10.22 Prospec Bio
10.22.1 Prospec Bio Basic Information
10.22.2 Prospec Bio Recombinant Human Annexin A1 Protein Product Overview
10.22.3 Prospec Bio Recombinant Human Annexin A1 Protein Product Market Performance
10.22.4 Prospec Bio Business Overview
10.22.5 Prospec Bio Recent Developments
10.23 Neuromics
10.23.1 Neuromics Basic Information
10.23.2 Neuromics Recombinant Human Annexin A1 Protein Product Overview
10.23.3 Neuromics Recombinant Human Annexin A1 Protein Product Market Performance
10.23.4 Neuromics Business Overview
10.23.5 Neuromics Recent Developments
11 RECOMBINANT HUMAN ANNEXIN A1 PROTEIN MARKET FORECAST BY REGION
11.1 Global Recombinant Human Annexin A1 Protein Market Size Forecast
11.2 Global Recombinant Human Annexin A1 Protein Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe Recombinant Human Annexin A1 Protein Market Size Forecast by Country
11.2.3 Asia Pacific Recombinant Human Annexin A1 Protein Market Size Forecast by Region
11.2.4 South America Recombinant Human Annexin A1 Protein Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Sales of Recombinant Human Annexin A1 Protein by Country
12 FORECAST MARKET BY TYPE AND BY APPLICATION (2026-2035)
12.1 Global Recombinant Human Annexin A1 Protein Market Forecast by Type (2026-2035)
12.1.1 Global Forecasted Sales of Recombinant Human Annexin A1 Protein by Type (2026-2035)
12.1.2 Global Recombinant Human Annexin A1 Protein Market Size Forecast by Type (2026-2035)
12.1.3 Global Forecasted Price of Recombinant Human Annexin A1 Protein by Type (2026-2035)
12.2 Global Recombinant Human Annexin A1 Protein Market Forecast by Application (2026-2035)
12.2.1 Global Recombinant Human Annexin A1 Protein Sales (K Units) Forecast by Application
12.2.2 Global Recombinant Human Annexin A1 Protein Market Size (M USD) Forecast by Application (2026-2035)
13 CONCLUSION AND KEY FINDINGS
1.1 Market Definition and Statistical Scope of Recombinant Human Annexin A1 Protein
1.2 Key Market Segments
1.2.1 Recombinant Human Annexin A1 Protein Segment by Type
1.2.2 Recombinant Human Annexin A1 Protein Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 RECOMBINANT HUMAN ANNEXIN A1 PROTEIN MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Recombinant Human Annexin A1 Protein Market Size (M USD) Estimates and Forecasts (2020-2035)
2.1.2 Global Recombinant Human Annexin A1 Protein Sales Estimates and Forecasts (2020-2035)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 RECOMBINANT HUMAN ANNEXIN A1 PROTEIN MARKET COMPETITIVE LANDSCAPE
3.1 Company Assessment Quadrant
3.2 Global Recombinant Human Annexin A1 Protein Product Life Cycle
3.3 Global Recombinant Human Annexin A1 Protein Sales by Manufacturers (2020-2025)
3.4 Global Recombinant Human Annexin A1 Protein Revenue Market Share by Manufacturers (2020-2025)
3.5 Recombinant Human Annexin A1 Protein Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Recombinant Human Annexin A1 Protein Average Price by Manufacturers (2020-2025)
3.7 Manufacturers? Manufacturing Sites, Areas Served, and Product Types
3.8 Recombinant Human Annexin A1 Protein Market Competitive Situation and Trends
3.8.1 Recombinant Human Annexin A1 Protein Market Concentration Rate
3.8.2 Global 5 and 10 Largest Recombinant Human Annexin A1 Protein Players Market Share by Revenue
3.8.3 Mergers & Acquisitions, Expansion
4 RECOMBINANT HUMAN ANNEXIN A1 PROTEIN INDUSTRY CHAIN ANALYSIS
4.1 Recombinant Human Annexin A1 Protein Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF RECOMBINANT HUMAN ANNEXIN A1 PROTEIN MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
5.4.1 New Product Developments
5.4.2 Mergers & Acquisitions
5.4.3 Expansions
5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
5.5.1 Industry Policies Analysis
5.5.2 Economic Environment Analysis
5.5.3 Social Environment Analysis
5.5.4 Technological Environment Analysis
5.6 Global Recombinant Human Annexin A1 Protein Market Porter's Five Forces Analysis
5.6.1 Global Trade Frictions
5.6.2 U.S. Tariff Policy ? April 2025
5.6.3 Global Trade Frictions and Their Impacts to Recombinant Human Annexin A1 Protein Market
5.7 ESG Ratings of Leading Companies
6 RECOMBINANT HUMAN ANNEXIN A1 PROTEIN MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Recombinant Human Annexin A1 Protein Sales Market Share by Type (2020-2025)
6.3 Global Recombinant Human Annexin A1 Protein Market Size by Type (2020-2025)
6.4 Global Recombinant Human Annexin A1 Protein Price by Type (2020-2025)
7 RECOMBINANT HUMAN ANNEXIN A1 PROTEIN MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Recombinant Human Annexin A1 Protein Market Sales by Application (2020-2025)
7.3 Global Recombinant Human Annexin A1 Protein Market Size (M USD) by Application (2020-2025)
7.4 Global Recombinant Human Annexin A1 Protein Sales Growth Rate by Application (2020-2025)
8 RECOMBINANT HUMAN ANNEXIN A1 PROTEIN MARKET SALES BY REGION
8.1 Global Recombinant Human Annexin A1 Protein Sales by Region
8.1.1 Global Recombinant Human Annexin A1 Protein Sales by Region
8.1.2 Global Recombinant Human Annexin A1 Protein Sales Market Share by Region
8.2 Global Recombinant Human Annexin A1 Protein Market Size by Region
8.2.1 Global Recombinant Human Annexin A1 Protein Market Size by Region
8.2.2 Global Recombinant Human Annexin A1 Protein Market Size by Region
8.3 North America
8.3.1 North America Recombinant Human Annexin A1 Protein Sales by Country
8.3.2 North America Recombinant Human Annexin A1 Protein Market Size by Country
8.3.3 U.S. Market Overview
8.3.4 Canada Market Overview
8.3.5 Mexico Market Overview
8.4 Europe
8.4.1 Europe Recombinant Human Annexin A1 Protein Sales by Country
8.4.2 Europe Recombinant Human Annexin A1 Protein Market Size by Country
8.4.3 Germany Market Overview
8.4.4 France Market Overview
8.4.5 U.K. Market Overview
8.4.6 Italy Market Overview
8.4.7 Spain Market Overview
8.5 Asia Pacific
8.5.1 Asia Pacific Recombinant Human Annexin A1 Protein Sales by Region
8.5.2 Asia Pacific Recombinant Human Annexin A1 Protein Market Size by Region
8.5.3 China Market Overview
8.5.4 Japan Market Overview
8.5.5 South Korea Market Overview
8.5.6 India Market Overview
8.5.7 Southeast Asia Market Overview
8.6 South America
8.6.1 South America Recombinant Human Annexin A1 Protein Sales by Country
8.6.2 South America Recombinant Human Annexin A1 Protein Market Size by Country
8.6.3 Brazil Market Overview
8.6.4 Argentina Market Overview
8.6.5 Columbia Market Overview
8.7 Middle East and Africa
8.7.1 Middle East and Africa Recombinant Human Annexin A1 Protein Sales by Region
8.7.2 Middle East and Africa Recombinant Human Annexin A1 Protein Market Size by Region
8.7.3 Saudi Arabia Market Overview
8.7.4 UAE Market Overview
8.7.5 Egypt Market Overview
8.7.6 Nigeria Market Overview
8.7.7 South Africa Market Overview
9 RECOMBINANT HUMAN ANNEXIN A1 PROTEIN MARKET PRODUCTION BY REGION
9.1 Global Production of Recombinant Human Annexin A1 Protein by Region(2020-2025)
9.2 Global Recombinant Human Annexin A1 Protein Revenue Market Share by Region (2020-2025)
9.3 Global Recombinant Human Annexin A1 Protein Production, Revenue, Price and Gross Margin (2020-2025)
9.4 North America Recombinant Human Annexin A1 Protein Production
9.4.1 North America Recombinant Human Annexin A1 Protein Production Growth Rate (2020-2025)
9.4.2 North America Recombinant Human Annexin A1 Protein Production, Revenue, Price and Gross Margin (2020-2025)
9.5 Europe Recombinant Human Annexin A1 Protein Production
9.5.1 Europe Recombinant Human Annexin A1 Protein Production Growth Rate (2020-2025)
9.5.2 Europe Recombinant Human Annexin A1 Protein Production, Revenue, Price and Gross Margin (2020-2025)
9.6 Japan Recombinant Human Annexin A1 Protein Production (2020-2025)
9.6.1 Japan Recombinant Human Annexin A1 Protein Production Growth Rate (2020-2025)
9.6.2 Japan Recombinant Human Annexin A1 Protein Production, Revenue, Price and Gross Margin (2020-2025)
9.7 China Recombinant Human Annexin A1 Protein Production (2020-2025)
9.7.1 China Recombinant Human Annexin A1 Protein Production Growth Rate (2020-2025)
9.7.2 China Recombinant Human Annexin A1 Protein Production, Revenue, Price and Gross Margin (2020-2025)
10 KEY COMPANIES PROFILE
10.1 Abcam
10.1.1 Abcam Basic Information
10.1.2 Abcam Recombinant Human Annexin A1 Protein Product Overview
10.1.3 Abcam Recombinant Human Annexin A1 Protein Product Market Performance
10.1.4 Abcam Business Overview
10.1.5 Abcam SWOT Analysis
10.1.6 Abcam Recent Developments
10.2 Novus Biologicals
10.2.1 Novus Biologicals Basic Information
10.2.2 Novus Biologicals Recombinant Human Annexin A1 Protein Product Overview
10.2.3 Novus Biologicals Recombinant Human Annexin A1 Protein Product Market Performance
10.2.4 Novus Biologicals Business Overview
10.2.5 Novus Biologicals SWOT Analysis
10.2.6 Novus Biologicals Recent Developments
10.3 QED Bioscience
10.3.1 QED Bioscience Basic Information
10.3.2 QED Bioscience Recombinant Human Annexin A1 Protein Product Overview
10.3.3 QED Bioscience Recombinant Human Annexin A1 Protein Product Market Performance
10.3.4 QED Bioscience Business Overview
10.3.5 QED Bioscience SWOT Analysis
10.3.6 QED Bioscience Recent Developments
10.4 Elabscience
10.4.1 Elabscience Basic Information
10.4.2 Elabscience Recombinant Human Annexin A1 Protein Product Overview
10.4.3 Elabscience Recombinant Human Annexin A1 Protein Product Market Performance
10.4.4 Elabscience Business Overview
10.4.5 Elabscience Recent Developments
10.5 Assay Genie
10.5.1 Assay Genie Basic Information
10.5.2 Assay Genie Recombinant Human Annexin A1 Protein Product Overview
10.5.3 Assay Genie Recombinant Human Annexin A1 Protein Product Market Performance
10.5.4 Assay Genie Business Overview
10.5.5 Assay Genie Recent Developments
10.6 Labome
10.6.1 Labome Basic Information
10.6.2 Labome Recombinant Human Annexin A1 Protein Product Overview
10.6.3 Labome Recombinant Human Annexin A1 Protein Product Market Performance
10.6.4 Labome Business Overview
10.6.5 Labome Recent Developments
10.7 Active Bioscience
10.7.1 Active Bioscience Basic Information
10.7.2 Active Bioscience Recombinant Human Annexin A1 Protein Product Overview
10.7.3 Active Bioscience Recombinant Human Annexin A1 Protein Product Market Performance
10.7.4 Active Bioscience Business Overview
10.7.5 Active Bioscience Recent Developments
10.8 Boster Bio
10.8.1 Boster Bio Basic Information
10.8.2 Boster Bio Recombinant Human Annexin A1 Protein Product Overview
10.8.3 Boster Bio Recombinant Human Annexin A1 Protein Product Market Performance
10.8.4 Boster Bio Business Overview
10.8.5 Boster Bio Recent Developments
10.9 Lifespan Biosciences
10.9.1 Lifespan Biosciences Basic Information
10.9.2 Lifespan Biosciences Recombinant Human Annexin A1 Protein Product Overview
10.9.3 Lifespan Biosciences Recombinant Human Annexin A1 Protein Product Market Performance
10.9.4 Lifespan Biosciences Business Overview
10.9.5 Lifespan Biosciences Recent Developments
10.10 RayBiotech
10.10.1 RayBiotech Basic Information
10.10.2 RayBiotech Recombinant Human Annexin A1 Protein Product Overview
10.10.3 RayBiotech Recombinant Human Annexin A1 Protein Product Market Performance
10.10.4 RayBiotech Business Overview
10.10.5 RayBiotech Recent Developments
10.11 Protein Alternatives
10.11.1 Protein Alternatives Basic Information
10.11.2 Protein Alternatives Recombinant Human Annexin A1 Protein Product Overview
10.11.3 Protein Alternatives Recombinant Human Annexin A1 Protein Product Market Performance
10.11.4 Protein Alternatives Business Overview
10.11.5 Protein Alternatives Recent Developments
10.12 enQuire BioReagents
10.12.1 enQuire BioReagents Basic Information
10.12.2 enQuire BioReagents Recombinant Human Annexin A1 Protein Product Overview
10.12.3 enQuire BioReagents Recombinant Human Annexin A1 Protein Product Market Performance
10.12.4 enQuire BioReagents Business Overview
10.12.5 enQuire BioReagents Recent Developments
10.13 Abeomics
10.13.1 Abeomics Basic Information
10.13.2 Abeomics Recombinant Human Annexin A1 Protein Product Overview
10.13.3 Abeomics Recombinant Human Annexin A1 Protein Product Market Performance
10.13.4 Abeomics Business Overview
10.13.5 Abeomics Recent Developments
10.14 Creative BioMart
10.14.1 Creative BioMart Basic Information
10.14.2 Creative BioMart Recombinant Human Annexin A1 Protein Product Overview
10.14.3 Creative BioMart Recombinant Human Annexin A1 Protein Product Market Performance
10.14.4 Creative BioMart Business Overview
10.14.5 Creative BioMart Recent Developments
10.15 KMD Bioscience
10.15.1 KMD Bioscience Basic Information
10.15.2 KMD Bioscience Recombinant Human Annexin A1 Protein Product Overview
10.15.3 KMD Bioscience Recombinant Human Annexin A1 Protein Product Market Performance
10.15.4 KMD Bioscience Business Overview
10.15.5 KMD Bioscience Recent Developments
10.16 OriGene
10.16.1 OriGene Basic Information
10.16.2 OriGene Recombinant Human Annexin A1 Protein Product Overview
10.16.3 OriGene Recombinant Human Annexin A1 Protein Product Market Performance
10.16.4 OriGene Business Overview
10.16.5 OriGene Recent Developments
10.17 MedChemExpress
10.17.1 MedChemExpress Basic Information
10.17.2 MedChemExpress Recombinant Human Annexin A1 Protein Product Overview
10.17.3 MedChemExpress Recombinant Human Annexin A1 Protein Product Market Performance
10.17.4 MedChemExpress Business Overview
10.17.5 MedChemExpress Recent Developments
10.18 Cusabio
10.18.1 Cusabio Basic Information
10.18.2 Cusabio Recombinant Human Annexin A1 Protein Product Overview
10.18.3 Cusabio Recombinant Human Annexin A1 Protein Product Market Performance
10.18.4 Cusabio Business Overview
10.18.5 Cusabio Recent Developments
10.19 Canvax
10.19.1 Canvax Basic Information
10.19.2 Canvax Recombinant Human Annexin A1 Protein Product Overview
10.19.3 Canvax Recombinant Human Annexin A1 Protein Product Market Performance
10.19.4 Canvax Business Overview
10.19.5 Canvax Recent Developments
10.20 Biorbyt
10.20.1 Biorbyt Basic Information
10.20.2 Biorbyt Recombinant Human Annexin A1 Protein Product Overview
10.20.3 Biorbyt Recombinant Human Annexin A1 Protein Product Market Performance
10.20.4 Biorbyt Business Overview
10.20.5 Biorbyt Recent Developments
10.21 Bon Opus Biosciences
10.21.1 Bon Opus Biosciences Basic Information
10.21.2 Bon Opus Biosciences Recombinant Human Annexin A1 Protein Product Overview
10.21.3 Bon Opus Biosciences Recombinant Human Annexin A1 Protein Product Market Performance
10.21.4 Bon Opus Biosciences Business Overview
10.21.5 Bon Opus Biosciences Recent Developments
10.22 Prospec Bio
10.22.1 Prospec Bio Basic Information
10.22.2 Prospec Bio Recombinant Human Annexin A1 Protein Product Overview
10.22.3 Prospec Bio Recombinant Human Annexin A1 Protein Product Market Performance
10.22.4 Prospec Bio Business Overview
10.22.5 Prospec Bio Recent Developments
10.23 Neuromics
10.23.1 Neuromics Basic Information
10.23.2 Neuromics Recombinant Human Annexin A1 Protein Product Overview
10.23.3 Neuromics Recombinant Human Annexin A1 Protein Product Market Performance
10.23.4 Neuromics Business Overview
10.23.5 Neuromics Recent Developments
11 RECOMBINANT HUMAN ANNEXIN A1 PROTEIN MARKET FORECAST BY REGION
11.1 Global Recombinant Human Annexin A1 Protein Market Size Forecast
11.2 Global Recombinant Human Annexin A1 Protein Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe Recombinant Human Annexin A1 Protein Market Size Forecast by Country
11.2.3 Asia Pacific Recombinant Human Annexin A1 Protein Market Size Forecast by Region
11.2.4 South America Recombinant Human Annexin A1 Protein Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Sales of Recombinant Human Annexin A1 Protein by Country
12 FORECAST MARKET BY TYPE AND BY APPLICATION (2026-2035)
12.1 Global Recombinant Human Annexin A1 Protein Market Forecast by Type (2026-2035)
12.1.1 Global Forecasted Sales of Recombinant Human Annexin A1 Protein by Type (2026-2035)
12.1.2 Global Recombinant Human Annexin A1 Protein Market Size Forecast by Type (2026-2035)
12.1.3 Global Forecasted Price of Recombinant Human Annexin A1 Protein by Type (2026-2035)
12.2 Global Recombinant Human Annexin A1 Protein Market Forecast by Application (2026-2035)
12.2.1 Global Recombinant Human Annexin A1 Protein Sales (K Units) Forecast by Application
12.2.2 Global Recombinant Human Annexin A1 Protein Market Size (M USD) Forecast by Application (2026-2035)
13 CONCLUSION AND KEY FINDINGS
LIST OF TABLES
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Global Recombinant Human Annexin A1 Protein Market Size by Type (M USD)
Table 4. Global Recombinant Human Annexin A1 Protein Market Size by Application
Table 5. Recombinant Human Annexin A1 Protein Market Size Comparison by Region (M USD)
Table 6. Global Recombinant Human Annexin A1 Protein Sales (K Units) by Manufacturers (2020-2025)
Table 7. Global Recombinant Human Annexin A1 Protein Sales Market Share by Manufacturers (2020-2025)
Table 8. Global Recombinant Human Annexin A1 Protein Revenue (M USD) by Manufacturers (2020-2025)
Table 9. Global Recombinant Human Annexin A1 Protein Revenue Share by Manufacturers (2020-2025)
Table 10. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Recombinant Human Annexin A1 Protein as of 2025)
Table 11. Global Market Recombinant Human Annexin A1 Protein Average Price (USD/Unit) of Key Manufacturers (2020-2025)
Table 12. Manufacturers? Manufacturing Sites, Areas Served
Table 13. Manufacturers? Product Type
Table 14. Global Recombinant Human Annexin A1 Protein Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Recombinant Human Annexin A1 Protein Market Challenges
Table 22. Goldman Sachs' forecast real GDP growth rate for 2025-2026
Table 23. S&P Global ' Forecast Real GDP Growth Rate For 2025-2027
Table 24. World Bank ' Forecast Real GDP Growth Rate For 2025-2026
Table 25. The Tariff Rates Imposed by the United States on Major Commodity Trading Countries
Table 26. Global Recombinant Human Annexin A1 Protein Sales by Type (K Units)
Table 27. Global Recombinant Human Annexin A1 Protein Market Size by Type (M USD)
Table 28. Global Recombinant Human Annexin A1 Protein Sales (K Units) by Type (2020-2025)
Table 29. Global Recombinant Human Annexin A1 Protein Sales Market Share by Type (2020-2025)
Table 30. Global Recombinant Human Annexin A1 Protein Market Size (M USD) by Type (2020-2025)
Table 31. Global Recombinant Human Annexin A1 Protein Market Share by Type (2020-2025)
Table 32. Global Recombinant Human Annexin A1 Protein Price (USD/Unit) by Type (2020-2025)
Table 33. Global Recombinant Human Annexin A1 Protein Sales (K Units) by Application
Table 34. Global Recombinant Human Annexin A1 Protein Market Size by Application
Table 35. Global Recombinant Human Annexin A1 Protein Sales by Application (2020-2025) & (K Units)
Table 36. Global Recombinant Human Annexin A1 Protein Sales Market Share by Application (2020-2025)
Table 37. Global Recombinant Human Annexin A1 Protein Market Size by Application (2020-2025) & (M USD)
Table 38. Global Recombinant Human Annexin A1 Protein Market Share by Application (2020-2025)
Table 39. Global Recombinant Human Annexin A1 Protein Sales Growth Rate by Application (2020-2025)
Table 40. Global Recombinant Human Annexin A1 Protein Sales by Region (2020-2025) & (K Units)
Table 41. Global Recombinant Human Annexin A1 Protein Sales Market Share by Region (2020-2025)
Table 42. Global Recombinant Human Annexin A1 Protein Market Size by Region (2020-2025) & (M USD)
Table 43. Global Recombinant Human Annexin A1 Protein Market Size by Region (2020-2025)
Table 44. North America Recombinant Human Annexin A1 Protein Sales by Country (2020-2025) & (K Units)
Table 45. North America Recombinant Human Annexin A1 Protein Market Size by Country (2020-2025) & (M USD)
Table 46. Europe Recombinant Human Annexin A1 Protein Sales by Country (2020-2025) & (K Units)
Table 47. Europe Recombinant Human Annexin A1 Protein Market Size by Country (2020-2025) & (M USD)
Table 48. Asia Pacific Recombinant Human Annexin A1 Protein Sales by Region (2020-2025) & (K Units)
Table 49. Asia Pacific Recombinant Human Annexin A1 Protein Market Size by Region (2020-2025) & (M USD)
Table 50. South America Recombinant Human Annexin A1 Protein Sales by Country (2020-2025) & (K Units)
Table 51. South America Recombinant Human Annexin A1 Protein Market Size by Country (2020-2025) & (M USD)
Table 52. Middle East and Africa Recombinant Human Annexin A1 Protein Sales by Region (2020-2025) & (K Units)
Table 53. Middle East and Africa Recombinant Human Annexin A1 Protein Market Size by Region (2020-2025) & (M USD)
Table 54. Global Recombinant Human Annexin A1 Protein Production (K Units) by Region(2020-2025)
Table 55. Global Recombinant Human Annexin A1 Protein Revenue (US$ Million) by Region (2020-2025)
Table 56. Global Recombinant Human Annexin A1 Protein Revenue Market Share by Region (2020-2025)
Table 57. Global Recombinant Human Annexin A1 Protein Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 58. North America Recombinant Human Annexin A1 Protein Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 59. Europe Recombinant Human Annexin A1 Protein Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 60. Japan Recombinant Human Annexin A1 Protein Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 61. China Recombinant Human Annexin A1 Protein Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 62. Abcam Basic Information
Table 63. Abcam Recombinant Human Annexin A1 Protein Product Overview
Table 64. Abcam Recombinant Human Annexin A1 Protein Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 65. Abcam Business Overview
Table 66. Abcam SWOT Analysis
Table 67. Abcam Recent Developments
Table 68. Novus Biologicals Basic Information
Table 69. Novus Biologicals Recombinant Human Annexin A1 Protein Product Overview
Table 70. Novus Biologicals Recombinant Human Annexin A1 Protein Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 71. Novus Biologicals Business Overview
Table 72. Novus Biologicals SWOT Analysis
Table 73. Novus Biologicals Recent Developments
Table 74. QED Bioscience Basic Information
Table 75. QED Bioscience Recombinant Human Annexin A1 Protein Product Overview
Table 76. QED Bioscience Recombinant Human Annexin A1 Protein Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 77. QED Bioscience Business Overview
Table 78. QED Bioscience SWOT Analysis
Table 79. QED Bioscience Recent Developments
Table 80. Elabscience Basic Information
Table 81. Elabscience Recombinant Human Annexin A1 Protein Product Overview
Table 82. Elabscience Recombinant Human Annexin A1 Protein Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 83. Elabscience Business Overview
Table 84. Elabscience Recent Developments
Table 85. Assay Genie Basic Information
Table 86. Assay Genie Recombinant Human Annexin A1 Protein Product Overview
Table 87. Assay Genie Recombinant Human Annexin A1 Protein Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 88. Assay Genie Business Overview
Table 89. Assay Genie Recent Developments
Table 90. Labome Basic Information
Table 91. Labome Recombinant Human Annexin A1 Protein Product Overview
Table 92. Labome Recombinant Human Annexin A1 Protein Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 93. Labome Business Overview
Table 94. Labome Recent Developments
Table 95. Active Bioscience Basic Information
Table 96. Active Bioscience Recombinant Human Annexin A1 Protein Product Overview
Table 97. Active Bioscience Recombinant Human Annexin A1 Protein Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 98. Active Bioscience Business Overview
Table 99. Active Bioscience Recent Developments
Table 100. Boster Bio Basic Information
Table 101. Boster Bio Recombinant Human Annexin A1 Protein Product Overview
Table 102. Boster Bio Recombinant Human Annexin A1 Protein Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 103. Boster Bio Business Overview
Table 104. Boster Bio Recent Developments
Table 105. Lifespan Biosciences Basic Information
Table 106. Lifespan Biosciences Recombinant Human Annexin A1 Protein Product Overview
Table 107. Lifespan Biosciences Recombinant Human Annexin A1 Protein Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 108. Lifespan Biosciences Business Overview
Table 109. Lifespan Biosciences Recent Developments
Table 110. RayBiotech Basic Information
Table 111. RayBiotech Recombinant Human Annexin A1 Protein Product Overview
Table 112. RayBiotech Recombinant Human Annexin A1 Protein Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 113. RayBiotech Business Overview
Table 114. RayBiotech Recent Developments
Table 115. Protein Alternatives Basic Information
Table 116. Protein Alternatives Recombinant Human Annexin A1 Protein Product Overview
Table 117. Protein Alternatives Recombinant Human Annexin A1 Protein Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 118. Protein Alternatives Business Overview
Table 119. Protein Alternatives Recent Developments
Table 120. enQuire BioReagents Basic Information
Table 121. enQuire BioReagents Recombinant Human Annexin A1 Protein Product Overview
Table 122. enQuire BioReagents Recombinant Human Annexin A1 Protein Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 123. enQuire BioReagents Business Overview
Table 124. enQuire BioReagents Recent Developments
Table 125. Abeomics Basic Information
Table 126. Abeomics Recombinant Human Annexin A1 Protein Product Overview
Table 127. Abeomics Recombinant Human Annexin A1 Protein Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 128. Abeomics Business Overview
Table 129. Abeomics Recent Developments
Table 130. Creative BioMart Basic Information
Table 131. Creative BioMart Recombinant Human Annexin A1 Protein Product Overview
Table 132. Creative BioMart Recombinant Human Annexin A1 Protein Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 133. Creative BioMart Business Overview
Table 134. Creative BioMart Recent Developments
Table 135. KMD Bioscience Basic Information
Table 136. KMD Bioscience Recombinant Human Annexin A1 Protein Product Overview
Table 137. KMD Bioscience Recombinant Human Annexin A1 Protein Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 138. KMD Bioscience Business Overview
Table 139. KMD Bioscience Recent Developments
Table 140. OriGene Basic Information
Table 141. OriGene Recombinant Human Annexin A1 Protein Product Overview
Table 142. OriGene Recombinant Human Annexin A1 Protein Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 143. OriGene Business Overview
Table 144. OriGene Recent Developments
Table 145. MedChemExpress Basic Information
Table 146. MedChemExpress Recombinant Human Annexin A1 Protein Product Overview
Table 147. MedChemExpress Recombinant Human Annexin A1 Protein Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 148. MedChemExpress Business Overview
Table 149. MedChemExpress Recent Developments
Table 150. Cusabio Basic Information
Table 151. Cusabio Recombinant Human Annexin A1 Protein Product Overview
Table 152. Cusabio Recombinant Human Annexin A1 Protein Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 153. Cusabio Business Overview
Table 154. Cusabio Recent Developments
Table 155. Canvax Basic Information
Table 156. Canvax Recombinant Human Annexin A1 Protein Product Overview
Table 157. Canvax Recombinant Human Annexin A1 Protein Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 158. Canvax Business Overview
Table 159. Canvax Recent Developments
Table 160. Biorbyt Basic Information
Table 161. Biorbyt Recombinant Human Annexin A1 Protein Product Overview
Table 162. Biorbyt Recombinant Human Annexin A1 Protein Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 163. Biorbyt Business Overview
Table 164. Biorbyt Recent Developments
Table 165. Bon Opus Biosciences Basic Information
Table 166. Bon Opus Biosciences Recombinant Human Annexin A1 Protein Product Overview
Table 167. Bon Opus Biosciences Recombinant Human Annexin A1 Protein Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 168. Bon Opus Biosciences Business Overview
Table 169. Bon Opus Biosciences Recent Developments
Table 170. Prospec Bio Basic Information
Table 171. Prospec Bio Recombinant Human Annexin A1 Protein Product Overview
Table 172. Prospec Bio Recombinant Human Annexin A1 Protein Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 173. Prospec Bio Business Overview
Table 174. Prospec Bio Recent Developments
Table 175. Neuromics Basic Information
Table 176. Neuromics Recombinant Human Annexin A1 Protein Product Overview
Table 177. Neuromics Recombinant Human Annexin A1 Protein Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 178. Neuromics Business Overview
Table 179. Neuromics Recent Developments
Table 180. Global Recombinant Human Annexin A1 Protein Sales Forecast by Region (2026-2035) & (K Units)
Table 181. Global Recombinant Human Annexin A1 Protein Market Size Forecast by Region (2026-2035) & (M USD)
Table 182. North America Recombinant Human Annexin A1 Protein Sales Forecast by Country (2026-2035) & (K Units)
Table 183. North America Recombinant Human Annexin A1 Protein Market Size Forecast by Country (2026-2035) & (M USD)
Table 184. Europe Recombinant Human Annexin A1 Protein Sales Forecast by Country (2026-2035) & (K Units)
Table 185. Europe Recombinant Human Annexin A1 Protein Market Size Forecast by Country (2026-2035) & (M USD)
Table 186. Asia Pacific Recombinant Human Annexin A1 Protein Sales Forecast by Region (2026-2035) & (K Units)
Table 187. Asia Pacific Recombinant Human Annexin A1 Protein Market Size Forecast by Region (2026-2035) & (M USD)
Table 188. South America Recombinant Human Annexin A1 Protein Sales Forecast by Country (2026-2035) & (K Units)
Table 189. South America Recombinant Human Annexin A1 Protein Market Size Forecast by Country (2026-2035) & (M USD)
Table 190. Middle East and Africa Recombinant Human Annexin A1 Protein Sales Forecast by Country (2026-2035) & (Units)
Table 191. Middle East and Africa Recombinant Human Annexin A1 Protein Market Size Forecast by Country (2026-2035) & (M USD)
Table 192. Global Recombinant Human Annexin A1 Protein Sales Forecast by Type (2026-2035) & (K Units)
Table 193. Global Recombinant Human Annexin A1 Protein Market Size Forecast by Type (2026-2035) & (M USD)
Table 194. Global Recombinant Human Annexin A1 Protein Price Forecast by Type (2026-2035) & (USD/Unit)
Table 195. Global Recombinant Human Annexin A1 Protein Sales (K Units) Forecast by Application (2026-2035)
Table 196. Global Recombinant Human Annexin A1 Protein Market Size Forecast by Application (2026-2035) & (M USD)
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Global Recombinant Human Annexin A1 Protein Market Size by Type (M USD)
Table 4. Global Recombinant Human Annexin A1 Protein Market Size by Application
Table 5. Recombinant Human Annexin A1 Protein Market Size Comparison by Region (M USD)
Table 6. Global Recombinant Human Annexin A1 Protein Sales (K Units) by Manufacturers (2020-2025)
Table 7. Global Recombinant Human Annexin A1 Protein Sales Market Share by Manufacturers (2020-2025)
Table 8. Global Recombinant Human Annexin A1 Protein Revenue (M USD) by Manufacturers (2020-2025)
Table 9. Global Recombinant Human Annexin A1 Protein Revenue Share by Manufacturers (2020-2025)
Table 10. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Recombinant Human Annexin A1 Protein as of 2025)
Table 11. Global Market Recombinant Human Annexin A1 Protein Average Price (USD/Unit) of Key Manufacturers (2020-2025)
Table 12. Manufacturers? Manufacturing Sites, Areas Served
Table 13. Manufacturers? Product Type
Table 14. Global Recombinant Human Annexin A1 Protein Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Recombinant Human Annexin A1 Protein Market Challenges
Table 22. Goldman Sachs' forecast real GDP growth rate for 2025-2026
Table 23. S&P Global ' Forecast Real GDP Growth Rate For 2025-2027
Table 24. World Bank ' Forecast Real GDP Growth Rate For 2025-2026
Table 25. The Tariff Rates Imposed by the United States on Major Commodity Trading Countries
Table 26. Global Recombinant Human Annexin A1 Protein Sales by Type (K Units)
Table 27. Global Recombinant Human Annexin A1 Protein Market Size by Type (M USD)
Table 28. Global Recombinant Human Annexin A1 Protein Sales (K Units) by Type (2020-2025)
Table 29. Global Recombinant Human Annexin A1 Protein Sales Market Share by Type (2020-2025)
Table 30. Global Recombinant Human Annexin A1 Protein Market Size (M USD) by Type (2020-2025)
Table 31. Global Recombinant Human Annexin A1 Protein Market Share by Type (2020-2025)
Table 32. Global Recombinant Human Annexin A1 Protein Price (USD/Unit) by Type (2020-2025)
Table 33. Global Recombinant Human Annexin A1 Protein Sales (K Units) by Application
Table 34. Global Recombinant Human Annexin A1 Protein Market Size by Application
Table 35. Global Recombinant Human Annexin A1 Protein Sales by Application (2020-2025) & (K Units)
Table 36. Global Recombinant Human Annexin A1 Protein Sales Market Share by Application (2020-2025)
Table 37. Global Recombinant Human Annexin A1 Protein Market Size by Application (2020-2025) & (M USD)
Table 38. Global Recombinant Human Annexin A1 Protein Market Share by Application (2020-2025)
Table 39. Global Recombinant Human Annexin A1 Protein Sales Growth Rate by Application (2020-2025)
Table 40. Global Recombinant Human Annexin A1 Protein Sales by Region (2020-2025) & (K Units)
Table 41. Global Recombinant Human Annexin A1 Protein Sales Market Share by Region (2020-2025)
Table 42. Global Recombinant Human Annexin A1 Protein Market Size by Region (2020-2025) & (M USD)
Table 43. Global Recombinant Human Annexin A1 Protein Market Size by Region (2020-2025)
Table 44. North America Recombinant Human Annexin A1 Protein Sales by Country (2020-2025) & (K Units)
Table 45. North America Recombinant Human Annexin A1 Protein Market Size by Country (2020-2025) & (M USD)
Table 46. Europe Recombinant Human Annexin A1 Protein Sales by Country (2020-2025) & (K Units)
Table 47. Europe Recombinant Human Annexin A1 Protein Market Size by Country (2020-2025) & (M USD)
Table 48. Asia Pacific Recombinant Human Annexin A1 Protein Sales by Region (2020-2025) & (K Units)
Table 49. Asia Pacific Recombinant Human Annexin A1 Protein Market Size by Region (2020-2025) & (M USD)
Table 50. South America Recombinant Human Annexin A1 Protein Sales by Country (2020-2025) & (K Units)
Table 51. South America Recombinant Human Annexin A1 Protein Market Size by Country (2020-2025) & (M USD)
Table 52. Middle East and Africa Recombinant Human Annexin A1 Protein Sales by Region (2020-2025) & (K Units)
Table 53. Middle East and Africa Recombinant Human Annexin A1 Protein Market Size by Region (2020-2025) & (M USD)
Table 54. Global Recombinant Human Annexin A1 Protein Production (K Units) by Region(2020-2025)
Table 55. Global Recombinant Human Annexin A1 Protein Revenue (US$ Million) by Region (2020-2025)
Table 56. Global Recombinant Human Annexin A1 Protein Revenue Market Share by Region (2020-2025)
Table 57. Global Recombinant Human Annexin A1 Protein Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 58. North America Recombinant Human Annexin A1 Protein Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 59. Europe Recombinant Human Annexin A1 Protein Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 60. Japan Recombinant Human Annexin A1 Protein Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 61. China Recombinant Human Annexin A1 Protein Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 62. Abcam Basic Information
Table 63. Abcam Recombinant Human Annexin A1 Protein Product Overview
Table 64. Abcam Recombinant Human Annexin A1 Protein Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 65. Abcam Business Overview
Table 66. Abcam SWOT Analysis
Table 67. Abcam Recent Developments
Table 68. Novus Biologicals Basic Information
Table 69. Novus Biologicals Recombinant Human Annexin A1 Protein Product Overview
Table 70. Novus Biologicals Recombinant Human Annexin A1 Protein Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 71. Novus Biologicals Business Overview
Table 72. Novus Biologicals SWOT Analysis
Table 73. Novus Biologicals Recent Developments
Table 74. QED Bioscience Basic Information
Table 75. QED Bioscience Recombinant Human Annexin A1 Protein Product Overview
Table 76. QED Bioscience Recombinant Human Annexin A1 Protein Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 77. QED Bioscience Business Overview
Table 78. QED Bioscience SWOT Analysis
Table 79. QED Bioscience Recent Developments
Table 80. Elabscience Basic Information
Table 81. Elabscience Recombinant Human Annexin A1 Protein Product Overview
Table 82. Elabscience Recombinant Human Annexin A1 Protein Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 83. Elabscience Business Overview
Table 84. Elabscience Recent Developments
Table 85. Assay Genie Basic Information
Table 86. Assay Genie Recombinant Human Annexin A1 Protein Product Overview
Table 87. Assay Genie Recombinant Human Annexin A1 Protein Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 88. Assay Genie Business Overview
Table 89. Assay Genie Recent Developments
Table 90. Labome Basic Information
Table 91. Labome Recombinant Human Annexin A1 Protein Product Overview
Table 92. Labome Recombinant Human Annexin A1 Protein Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 93. Labome Business Overview
Table 94. Labome Recent Developments
Table 95. Active Bioscience Basic Information
Table 96. Active Bioscience Recombinant Human Annexin A1 Protein Product Overview
Table 97. Active Bioscience Recombinant Human Annexin A1 Protein Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 98. Active Bioscience Business Overview
Table 99. Active Bioscience Recent Developments
Table 100. Boster Bio Basic Information
Table 101. Boster Bio Recombinant Human Annexin A1 Protein Product Overview
Table 102. Boster Bio Recombinant Human Annexin A1 Protein Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 103. Boster Bio Business Overview
Table 104. Boster Bio Recent Developments
Table 105. Lifespan Biosciences Basic Information
Table 106. Lifespan Biosciences Recombinant Human Annexin A1 Protein Product Overview
Table 107. Lifespan Biosciences Recombinant Human Annexin A1 Protein Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 108. Lifespan Biosciences Business Overview
Table 109. Lifespan Biosciences Recent Developments
Table 110. RayBiotech Basic Information
Table 111. RayBiotech Recombinant Human Annexin A1 Protein Product Overview
Table 112. RayBiotech Recombinant Human Annexin A1 Protein Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 113. RayBiotech Business Overview
Table 114. RayBiotech Recent Developments
Table 115. Protein Alternatives Basic Information
Table 116. Protein Alternatives Recombinant Human Annexin A1 Protein Product Overview
Table 117. Protein Alternatives Recombinant Human Annexin A1 Protein Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 118. Protein Alternatives Business Overview
Table 119. Protein Alternatives Recent Developments
Table 120. enQuire BioReagents Basic Information
Table 121. enQuire BioReagents Recombinant Human Annexin A1 Protein Product Overview
Table 122. enQuire BioReagents Recombinant Human Annexin A1 Protein Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 123. enQuire BioReagents Business Overview
Table 124. enQuire BioReagents Recent Developments
Table 125. Abeomics Basic Information
Table 126. Abeomics Recombinant Human Annexin A1 Protein Product Overview
Table 127. Abeomics Recombinant Human Annexin A1 Protein Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 128. Abeomics Business Overview
Table 129. Abeomics Recent Developments
Table 130. Creative BioMart Basic Information
Table 131. Creative BioMart Recombinant Human Annexin A1 Protein Product Overview
Table 132. Creative BioMart Recombinant Human Annexin A1 Protein Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 133. Creative BioMart Business Overview
Table 134. Creative BioMart Recent Developments
Table 135. KMD Bioscience Basic Information
Table 136. KMD Bioscience Recombinant Human Annexin A1 Protein Product Overview
Table 137. KMD Bioscience Recombinant Human Annexin A1 Protein Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 138. KMD Bioscience Business Overview
Table 139. KMD Bioscience Recent Developments
Table 140. OriGene Basic Information
Table 141. OriGene Recombinant Human Annexin A1 Protein Product Overview
Table 142. OriGene Recombinant Human Annexin A1 Protein Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 143. OriGene Business Overview
Table 144. OriGene Recent Developments
Table 145. MedChemExpress Basic Information
Table 146. MedChemExpress Recombinant Human Annexin A1 Protein Product Overview
Table 147. MedChemExpress Recombinant Human Annexin A1 Protein Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 148. MedChemExpress Business Overview
Table 149. MedChemExpress Recent Developments
Table 150. Cusabio Basic Information
Table 151. Cusabio Recombinant Human Annexin A1 Protein Product Overview
Table 152. Cusabio Recombinant Human Annexin A1 Protein Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 153. Cusabio Business Overview
Table 154. Cusabio Recent Developments
Table 155. Canvax Basic Information
Table 156. Canvax Recombinant Human Annexin A1 Protein Product Overview
Table 157. Canvax Recombinant Human Annexin A1 Protein Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 158. Canvax Business Overview
Table 159. Canvax Recent Developments
Table 160. Biorbyt Basic Information
Table 161. Biorbyt Recombinant Human Annexin A1 Protein Product Overview
Table 162. Biorbyt Recombinant Human Annexin A1 Protein Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 163. Biorbyt Business Overview
Table 164. Biorbyt Recent Developments
Table 165. Bon Opus Biosciences Basic Information
Table 166. Bon Opus Biosciences Recombinant Human Annexin A1 Protein Product Overview
Table 167. Bon Opus Biosciences Recombinant Human Annexin A1 Protein Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 168. Bon Opus Biosciences Business Overview
Table 169. Bon Opus Biosciences Recent Developments
Table 170. Prospec Bio Basic Information
Table 171. Prospec Bio Recombinant Human Annexin A1 Protein Product Overview
Table 172. Prospec Bio Recombinant Human Annexin A1 Protein Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 173. Prospec Bio Business Overview
Table 174. Prospec Bio Recent Developments
Table 175. Neuromics Basic Information
Table 176. Neuromics Recombinant Human Annexin A1 Protein Product Overview
Table 177. Neuromics Recombinant Human Annexin A1 Protein Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 178. Neuromics Business Overview
Table 179. Neuromics Recent Developments
Table 180. Global Recombinant Human Annexin A1 Protein Sales Forecast by Region (2026-2035) & (K Units)
Table 181. Global Recombinant Human Annexin A1 Protein Market Size Forecast by Region (2026-2035) & (M USD)
Table 182. North America Recombinant Human Annexin A1 Protein Sales Forecast by Country (2026-2035) & (K Units)
Table 183. North America Recombinant Human Annexin A1 Protein Market Size Forecast by Country (2026-2035) & (M USD)
Table 184. Europe Recombinant Human Annexin A1 Protein Sales Forecast by Country (2026-2035) & (K Units)
Table 185. Europe Recombinant Human Annexin A1 Protein Market Size Forecast by Country (2026-2035) & (M USD)
Table 186. Asia Pacific Recombinant Human Annexin A1 Protein Sales Forecast by Region (2026-2035) & (K Units)
Table 187. Asia Pacific Recombinant Human Annexin A1 Protein Market Size Forecast by Region (2026-2035) & (M USD)
Table 188. South America Recombinant Human Annexin A1 Protein Sales Forecast by Country (2026-2035) & (K Units)
Table 189. South America Recombinant Human Annexin A1 Protein Market Size Forecast by Country (2026-2035) & (M USD)
Table 190. Middle East and Africa Recombinant Human Annexin A1 Protein Sales Forecast by Country (2026-2035) & (Units)
Table 191. Middle East and Africa Recombinant Human Annexin A1 Protein Market Size Forecast by Country (2026-2035) & (M USD)
Table 192. Global Recombinant Human Annexin A1 Protein Sales Forecast by Type (2026-2035) & (K Units)
Table 193. Global Recombinant Human Annexin A1 Protein Market Size Forecast by Type (2026-2035) & (M USD)
Table 194. Global Recombinant Human Annexin A1 Protein Price Forecast by Type (2026-2035) & (USD/Unit)
Table 195. Global Recombinant Human Annexin A1 Protein Sales (K Units) Forecast by Application (2026-2035)
Table 196. Global Recombinant Human Annexin A1 Protein Market Size Forecast by Application (2026-2035) & (M USD)
LIST OF FIGURES
Figure 1. Product Picture of Recombinant Human Annexin A1 Protein
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Recombinant Human Annexin A1 Protein Market Size (M USD), 2025-2035
Figure 5. Global Recombinant Human Annexin A1 Protein Market Size (M USD) (2020-2035)
Figure 6. Global Recombinant Human Annexin A1 Protein Sales (K Units) & (2020-2035)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Recombinant Human Annexin A1 Protein Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global Recombinant Human Annexin A1 Protein Product Life Cycle
Figure 13. Recombinant Human Annexin A1 Protein Sales Share by Manufacturers in 2025
Figure 14. Global Recombinant Human Annexin A1 Protein Revenue Share by Manufacturers in 2025
Figure 15. Recombinant Human Annexin A1 Protein Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2025
Figure 16. Global Market Recombinant Human Annexin A1 Protein Average Price (USD/Unit) of Key Manufacturers in 2025
Figure 17. The Global 5 and 10 Largest Players: Market Share by Recombinant Human Annexin A1 Protein Revenue in 2025
Figure 18. Industry Chain Map of Recombinant Human Annexin A1 Protein
Figure 19. Global Recombinant Human Annexin A1 Protein Market PEST Analysis
Figure 20. Global Recombinant Human Annexin A1 Protein Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 26. Global Recombinant Human Annexin A1 Protein Market Share by Type
Figure 27. Sales Market Share of Recombinant Human Annexin A1 Protein by Type (2020-2025)
Figure 28. Sales Market Share of Recombinant Human Annexin A1 Protein by Type in 2025
Figure 29. Market Share of Recombinant Human Annexin A1 Protein by Type (2020-2025)
Figure 30. Market Share of Recombinant Human Annexin A1 Protein by Type in 2025
Figure 31. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 32. Global Recombinant Human Annexin A1 Protein Market Share by Application
Figure 33. Global Recombinant Human Annexin A1 Protein Sales Market Share by Application (2020-2025)
Figure 34. Global Recombinant Human Annexin A1 Protein Sales Market Share by Application in 2025
Figure 35. Global Recombinant Human Annexin A1 Protein Market Share by Application (2020-2025)
Figure 36. Global Recombinant Human Annexin A1 Protein Market Share by Application in 2025
Figure 37. Global Recombinant Human Annexin A1 Protein Sales Growth Rate by Application (2020-2025)
Figure 38. Global Recombinant Human Annexin A1 Protein Sales Market Share by Region (2020-2025)
Figure 39. Global Recombinant Human Annexin A1 Protein Market Size by Region (2020-2025)
Figure 40. North America Recombinant Human Annexin A1 Protein Sales and Growth Rate (2020-2025) & (K Units)
Figure 41. North America Recombinant Human Annexin A1 Protein Sales and Growth Rate (2020-2025) & (K Units)
Figure 42. North America Recombinant Human Annexin A1 Protein Sales Market Share by Country in 2024
Figure 43. North America Recombinant Human Annexin A1 Protein Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. North America Recombinant Human Annexin A1 Protein Market Size by Country in 2024
Figure 45. U.S. Recombinant Human Annexin A1 Protein Sales and Growth Rate (2020-2025) & (K Units)
Figure 46. U.S. Recombinant Human Annexin A1 Protein Market Size and Growth Rate (2020-2025) & (M USD)
Figure 47. Canada Recombinant Human Annexin A1 Protein Sales (K Units) and Growth Rate (2020-2025)
Figure 48. Canada Recombinant Human Annexin A1 Protein Market Size (M USD) and Growth Rate (2020-2025)
Figure 49. Mexico Recombinant Human Annexin A1 Protein Sales (Units) and Growth Rate (2020-2025)
Figure 50. Mexico Recombinant Human Annexin A1 Protein Market Size (Units) and Growth Rate (2020-2025)
Figure 51. Europe Recombinant Human Annexin A1 Protein Sales and Growth Rate (2020-2025) & (K Units)
Figure 52. Europe Recombinant Human Annexin A1 Protein Sales Market Share by Country in 2024
Figure 53. Europe Recombinant Human Annexin A1 Protein Market Size and Growth Rate (2020-2025) & (M USD)
Figure 54. Europe Recombinant Human Annexin A1 Protein Market Size by Country in 2024
Figure 55. Germany Recombinant Human Annexin A1 Protein Sales and Growth Rate (2020-2025) & (K Units)
Figure 56. Germany Recombinant Human Annexin A1 Protein Market Size and Growth Rate (2020-2025) & (M USD)
Figure 57. France Recombinant Human Annexin A1 Protein Sales and Growth Rate (2020-2025) & (K Units)
Figure 58. France Recombinant Human Annexin A1 Protein Market Size and Growth Rate (2020-2025) & (M USD)
Figure 59. U.K. Recombinant Human Annexin A1 Protein Sales and Growth Rate (2020-2025) & (K Units)
Figure 60. U.K. Recombinant Human Annexin A1 Protein Market Size and Growth Rate (2020-2025) & (M USD)
Figure 61. Italy Recombinant Human Annexin A1 Protein Sales and Growth Rate (2020-2025) & (K Units)
Figure 62. Italy Recombinant Human Annexin A1 Protein Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. Spain Recombinant Human Annexin A1 Protein Sales and Growth Rate (2020-2025) & (K Units)
Figure 64. Spain Recombinant Human Annexin A1 Protein Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. Asia Pacific Recombinant Human Annexin A1 Protein Sales and Growth Rate (K Units)
Figure 66. Asia Pacific Recombinant Human Annexin A1 Protein Sales Market Share by Region in 2024
Figure 67. Asia Pacific Recombinant Human Annexin A1 Protein Market Size by Region in 2024
Figure 68. China Recombinant Human Annexin A1 Protein Sales and Growth Rate (2020-2025) & (K Units)
Figure 69. China Recombinant Human Annexin A1 Protein Market Size and Growth Rate (2020-2025) & (M USD)
Figure 70. Japan Recombinant Human Annexin A1 Protein Sales and Growth Rate (2020-2025) & (K Units)
Figure 71. Japan Recombinant Human Annexin A1 Protein Market Size and Growth Rate (2020-2025) & (M USD)
Figure 72. South Korea Recombinant Human Annexin A1 Protein Sales and Growth Rate (2020-2025) & (K Units)
Figure 73. South Korea Recombinant Human Annexin A1 Protein Market Size and Growth Rate (2020-2025) & (M USD)
Figure 74. India Recombinant Human Annexin A1 Protein Sales and Growth Rate (2020-2025) & (K Units)
Figure 75. India Recombinant Human Annexin A1 Protein Market Size and Growth Rate (2020-2025) & (M USD)
Figure 76. Southeast Asia Recombinant Human Annexin A1 Protein Sales and Growth Rate (2020-2025) & (K Units)
Figure 77. Southeast Asia Recombinant Human Annexin A1 Protein Market Size and Growth Rate (2020-2025) & (M USD)
Figure 78. South America Recombinant Human Annexin A1 Protein Sales and Growth Rate (K Units)
Figure 79. South America Recombinant Human Annexin A1 Protein Sales Market Share by Country in 2024
Figure 80. South America Recombinant Human Annexin A1 Protein Market Size and Growth Rate (M USD)
Figure 81. South America Recombinant Human Annexin A1 Protein Market Size by Country in 2024
Figure 82. Brazil Recombinant Human Annexin A1 Protein Sales and Growth Rate (2020-2025) & (K Units)
Figure 83. Brazil Recombinant Human Annexin A1 Protein Market Size and Growth Rate (2020-2025) & (M USD)
Figure 84. Argentina Recombinant Human Annexin A1 Protein Sales and Growth Rate (2020-2025) & (K Units)
Figure 85. Argentina Recombinant Human Annexin A1 Protein Market Size and Growth Rate (2020-2025) & (M USD)
Figure 86. Columbia Recombinant Human Annexin A1 Protein Sales and Growth Rate (2020-2025) & (K Units)
Figure 87. Columbia Recombinant Human Annexin A1 Protein Market Size and Growth Rate (2020-2025) & (M USD)
Figure 88. Middle East and Africa Recombinant Human Annexin A1 Protein Sales and Growth Rate (K Units)
Figure 89. Middle East and Africa Recombinant Human Annexin A1 Protein Sales Market Share by Region in 2024
Figure 90. Middle East and Africa Recombinant Human Annexin A1 Protein Market Size and Growth Rate (M USD)
Figure 91. Middle East and Africa Recombinant Human Annexin A1 Protein Market Size by Region in 2024
Figure 92. Saudi Arabia Recombinant Human Annexin A1 Protein Sales and Growth Rate (2020-2025) & (K Units)
Figure 93. Saudi Arabia Recombinant Human Annexin A1 Protein Market Size and Growth Rate (2020-2025) & (M USD)
Figure 94. UAE Recombinant Human Annexin A1 Protein Sales and Growth Rate (2020-2025) & (K Units)
Figure 95. UAE Recombinant Human Annexin A1 Protein Market Size and Growth Rate (2020-2025) & (M USD)
Figure 96. Egypt Recombinant Human Annexin A1 Protein Sales and Growth Rate (2020-2025) & (K Units)
Figure 97. Egypt Recombinant Human Annexin A1 Protein Market Size and Growth Rate (2020-2025) & (M USD)
Figure 98. Nigeria Recombinant Human Annexin A1 Protein Sales and Growth Rate (2020-2025) & (K Units)
Figure 99. Nigeria Recombinant Human Annexin A1 Protein Market Size and Growth Rate (2020-2025) & (M USD)
Figure 100. South Africa Recombinant Human Annexin A1 Protein Sales and Growth Rate (2020-2025) & (K Units)
Figure 101. South Africa Recombinant Human Annexin A1 Protein Market Size and Growth Rate (2020-2025) & (M USD)
Figure 102. Global Recombinant Human Annexin A1 Protein Production Market Share by Region (2020-2025)
Figure 103. North America Recombinant Human Annexin A1 Protein Production (K Units) Growth Rate (2020-2025)
Figure 104. Europe Recombinant Human Annexin A1 Protein Production (K Units) Growth Rate (2020-2025)
Figure 105. Japan Recombinant Human Annexin A1 Protein Production (K Units) Growth Rate (2020-2025)
Figure 106. China Recombinant Human Annexin A1 Protein Production (K Units) Growth Rate (2020-2025)
Figure 107. Global Recombinant Human Annexin A1 Protein Sales Forecast by Volume (2020-2035) & (K Units)
Figure 108. Global Recombinant Human Annexin A1 Protein Market Size Forecast by Value (2020-2035) & (M USD)
Figure 109. Global Recombinant Human Annexin A1 Protein Sales Market Share Forecast by Type (2026-2035)
Figure 110. Global Recombinant Human Annexin A1 Protein Market Share Forecast by Type (2026-2035)
Figure 111. Global Recombinant Human Annexin A1 Protein Sales Forecast by Application (2026-2035)
Figure 112. Global Recombinant Human Annexin A1 Protein Market Share Forecast by Application (2026-2035)
Figure 1. Product Picture of Recombinant Human Annexin A1 Protein
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Recombinant Human Annexin A1 Protein Market Size (M USD), 2025-2035
Figure 5. Global Recombinant Human Annexin A1 Protein Market Size (M USD) (2020-2035)
Figure 6. Global Recombinant Human Annexin A1 Protein Sales (K Units) & (2020-2035)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Recombinant Human Annexin A1 Protein Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global Recombinant Human Annexin A1 Protein Product Life Cycle
Figure 13. Recombinant Human Annexin A1 Protein Sales Share by Manufacturers in 2025
Figure 14. Global Recombinant Human Annexin A1 Protein Revenue Share by Manufacturers in 2025
Figure 15. Recombinant Human Annexin A1 Protein Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2025
Figure 16. Global Market Recombinant Human Annexin A1 Protein Average Price (USD/Unit) of Key Manufacturers in 2025
Figure 17. The Global 5 and 10 Largest Players: Market Share by Recombinant Human Annexin A1 Protein Revenue in 2025
Figure 18. Industry Chain Map of Recombinant Human Annexin A1 Protein
Figure 19. Global Recombinant Human Annexin A1 Protein Market PEST Analysis
Figure 20. Global Recombinant Human Annexin A1 Protein Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 26. Global Recombinant Human Annexin A1 Protein Market Share by Type
Figure 27. Sales Market Share of Recombinant Human Annexin A1 Protein by Type (2020-2025)
Figure 28. Sales Market Share of Recombinant Human Annexin A1 Protein by Type in 2025
Figure 29. Market Share of Recombinant Human Annexin A1 Protein by Type (2020-2025)
Figure 30. Market Share of Recombinant Human Annexin A1 Protein by Type in 2025
Figure 31. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 32. Global Recombinant Human Annexin A1 Protein Market Share by Application
Figure 33. Global Recombinant Human Annexin A1 Protein Sales Market Share by Application (2020-2025)
Figure 34. Global Recombinant Human Annexin A1 Protein Sales Market Share by Application in 2025
Figure 35. Global Recombinant Human Annexin A1 Protein Market Share by Application (2020-2025)
Figure 36. Global Recombinant Human Annexin A1 Protein Market Share by Application in 2025
Figure 37. Global Recombinant Human Annexin A1 Protein Sales Growth Rate by Application (2020-2025)
Figure 38. Global Recombinant Human Annexin A1 Protein Sales Market Share by Region (2020-2025)
Figure 39. Global Recombinant Human Annexin A1 Protein Market Size by Region (2020-2025)
Figure 40. North America Recombinant Human Annexin A1 Protein Sales and Growth Rate (2020-2025) & (K Units)
Figure 41. North America Recombinant Human Annexin A1 Protein Sales and Growth Rate (2020-2025) & (K Units)
Figure 42. North America Recombinant Human Annexin A1 Protein Sales Market Share by Country in 2024
Figure 43. North America Recombinant Human Annexin A1 Protein Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. North America Recombinant Human Annexin A1 Protein Market Size by Country in 2024
Figure 45. U.S. Recombinant Human Annexin A1 Protein Sales and Growth Rate (2020-2025) & (K Units)
Figure 46. U.S. Recombinant Human Annexin A1 Protein Market Size and Growth Rate (2020-2025) & (M USD)
Figure 47. Canada Recombinant Human Annexin A1 Protein Sales (K Units) and Growth Rate (2020-2025)
Figure 48. Canada Recombinant Human Annexin A1 Protein Market Size (M USD) and Growth Rate (2020-2025)
Figure 49. Mexico Recombinant Human Annexin A1 Protein Sales (Units) and Growth Rate (2020-2025)
Figure 50. Mexico Recombinant Human Annexin A1 Protein Market Size (Units) and Growth Rate (2020-2025)
Figure 51. Europe Recombinant Human Annexin A1 Protein Sales and Growth Rate (2020-2025) & (K Units)
Figure 52. Europe Recombinant Human Annexin A1 Protein Sales Market Share by Country in 2024
Figure 53. Europe Recombinant Human Annexin A1 Protein Market Size and Growth Rate (2020-2025) & (M USD)
Figure 54. Europe Recombinant Human Annexin A1 Protein Market Size by Country in 2024
Figure 55. Germany Recombinant Human Annexin A1 Protein Sales and Growth Rate (2020-2025) & (K Units)
Figure 56. Germany Recombinant Human Annexin A1 Protein Market Size and Growth Rate (2020-2025) & (M USD)
Figure 57. France Recombinant Human Annexin A1 Protein Sales and Growth Rate (2020-2025) & (K Units)
Figure 58. France Recombinant Human Annexin A1 Protein Market Size and Growth Rate (2020-2025) & (M USD)
Figure 59. U.K. Recombinant Human Annexin A1 Protein Sales and Growth Rate (2020-2025) & (K Units)
Figure 60. U.K. Recombinant Human Annexin A1 Protein Market Size and Growth Rate (2020-2025) & (M USD)
Figure 61. Italy Recombinant Human Annexin A1 Protein Sales and Growth Rate (2020-2025) & (K Units)
Figure 62. Italy Recombinant Human Annexin A1 Protein Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. Spain Recombinant Human Annexin A1 Protein Sales and Growth Rate (2020-2025) & (K Units)
Figure 64. Spain Recombinant Human Annexin A1 Protein Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. Asia Pacific Recombinant Human Annexin A1 Protein Sales and Growth Rate (K Units)
Figure 66. Asia Pacific Recombinant Human Annexin A1 Protein Sales Market Share by Region in 2024
Figure 67. Asia Pacific Recombinant Human Annexin A1 Protein Market Size by Region in 2024
Figure 68. China Recombinant Human Annexin A1 Protein Sales and Growth Rate (2020-2025) & (K Units)
Figure 69. China Recombinant Human Annexin A1 Protein Market Size and Growth Rate (2020-2025) & (M USD)
Figure 70. Japan Recombinant Human Annexin A1 Protein Sales and Growth Rate (2020-2025) & (K Units)
Figure 71. Japan Recombinant Human Annexin A1 Protein Market Size and Growth Rate (2020-2025) & (M USD)
Figure 72. South Korea Recombinant Human Annexin A1 Protein Sales and Growth Rate (2020-2025) & (K Units)
Figure 73. South Korea Recombinant Human Annexin A1 Protein Market Size and Growth Rate (2020-2025) & (M USD)
Figure 74. India Recombinant Human Annexin A1 Protein Sales and Growth Rate (2020-2025) & (K Units)
Figure 75. India Recombinant Human Annexin A1 Protein Market Size and Growth Rate (2020-2025) & (M USD)
Figure 76. Southeast Asia Recombinant Human Annexin A1 Protein Sales and Growth Rate (2020-2025) & (K Units)
Figure 77. Southeast Asia Recombinant Human Annexin A1 Protein Market Size and Growth Rate (2020-2025) & (M USD)
Figure 78. South America Recombinant Human Annexin A1 Protein Sales and Growth Rate (K Units)
Figure 79. South America Recombinant Human Annexin A1 Protein Sales Market Share by Country in 2024
Figure 80. South America Recombinant Human Annexin A1 Protein Market Size and Growth Rate (M USD)
Figure 81. South America Recombinant Human Annexin A1 Protein Market Size by Country in 2024
Figure 82. Brazil Recombinant Human Annexin A1 Protein Sales and Growth Rate (2020-2025) & (K Units)
Figure 83. Brazil Recombinant Human Annexin A1 Protein Market Size and Growth Rate (2020-2025) & (M USD)
Figure 84. Argentina Recombinant Human Annexin A1 Protein Sales and Growth Rate (2020-2025) & (K Units)
Figure 85. Argentina Recombinant Human Annexin A1 Protein Market Size and Growth Rate (2020-2025) & (M USD)
Figure 86. Columbia Recombinant Human Annexin A1 Protein Sales and Growth Rate (2020-2025) & (K Units)
Figure 87. Columbia Recombinant Human Annexin A1 Protein Market Size and Growth Rate (2020-2025) & (M USD)
Figure 88. Middle East and Africa Recombinant Human Annexin A1 Protein Sales and Growth Rate (K Units)
Figure 89. Middle East and Africa Recombinant Human Annexin A1 Protein Sales Market Share by Region in 2024
Figure 90. Middle East and Africa Recombinant Human Annexin A1 Protein Market Size and Growth Rate (M USD)
Figure 91. Middle East and Africa Recombinant Human Annexin A1 Protein Market Size by Region in 2024
Figure 92. Saudi Arabia Recombinant Human Annexin A1 Protein Sales and Growth Rate (2020-2025) & (K Units)
Figure 93. Saudi Arabia Recombinant Human Annexin A1 Protein Market Size and Growth Rate (2020-2025) & (M USD)
Figure 94. UAE Recombinant Human Annexin A1 Protein Sales and Growth Rate (2020-2025) & (K Units)
Figure 95. UAE Recombinant Human Annexin A1 Protein Market Size and Growth Rate (2020-2025) & (M USD)
Figure 96. Egypt Recombinant Human Annexin A1 Protein Sales and Growth Rate (2020-2025) & (K Units)
Figure 97. Egypt Recombinant Human Annexin A1 Protein Market Size and Growth Rate (2020-2025) & (M USD)
Figure 98. Nigeria Recombinant Human Annexin A1 Protein Sales and Growth Rate (2020-2025) & (K Units)
Figure 99. Nigeria Recombinant Human Annexin A1 Protein Market Size and Growth Rate (2020-2025) & (M USD)
Figure 100. South Africa Recombinant Human Annexin A1 Protein Sales and Growth Rate (2020-2025) & (K Units)
Figure 101. South Africa Recombinant Human Annexin A1 Protein Market Size and Growth Rate (2020-2025) & (M USD)
Figure 102. Global Recombinant Human Annexin A1 Protein Production Market Share by Region (2020-2025)
Figure 103. North America Recombinant Human Annexin A1 Protein Production (K Units) Growth Rate (2020-2025)
Figure 104. Europe Recombinant Human Annexin A1 Protein Production (K Units) Growth Rate (2020-2025)
Figure 105. Japan Recombinant Human Annexin A1 Protein Production (K Units) Growth Rate (2020-2025)
Figure 106. China Recombinant Human Annexin A1 Protein Production (K Units) Growth Rate (2020-2025)
Figure 107. Global Recombinant Human Annexin A1 Protein Sales Forecast by Volume (2020-2035) & (K Units)
Figure 108. Global Recombinant Human Annexin A1 Protein Market Size Forecast by Value (2020-2035) & (M USD)
Figure 109. Global Recombinant Human Annexin A1 Protein Sales Market Share Forecast by Type (2026-2035)
Figure 110. Global Recombinant Human Annexin A1 Protein Market Share Forecast by Type (2026-2035)
Figure 111. Global Recombinant Human Annexin A1 Protein Sales Forecast by Application (2026-2035)
Figure 112. Global Recombinant Human Annexin A1 Protein Market Share Forecast by Application (2026-2035)
